日本新薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4516/E00931 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2013/11/22 | 日証協 | 92,918株 | +2.21% | 70,584株 | -14.39% | 119,597株 | -12.45% | 29,000株 | -35.79% |
2013/11/15 | 日証協 | 90,913株 | +10.99% | 82,450株 | +73.12% | 136,597株 | +21.3% | 45,167株 | +803.34% |
2013/11/08 | 日証協 | 81,913株 | +1.79% | 47,626株 | -25.97% | 112,612株 | -2.62% | 5,000株 | -90.74% |
2013/11/01 | 日証協 | 80,475株 | -22.54% | 64,334株 | +111.51% | 115,637株 | -30.71% | 54,000株 | -13.78% |
2013/10/25 | 日証協 | 103,891株 | +0.73% | 30,416株 | -33.39% | 166,887株 | -8.75% | 62,634株 | -36.37% |
2013/10/18 | 日証協 | 103,141株 | -12.2% | 45,666株 | +79.26% | 182,887株 | +1.11% | 98,442株 | +43.83% |
2013/10/11 | 日証協 | 117,475株 | -5.01% | 25,475株 | -62.54% | 180,887株 | +4.29% | 68,442株 | -14.45% |
2013/10/04 | 日証協 | 123,675株 | +2.49% | 68,000株 | -2.23% | 173,440株 | -16.24% | 80,005株 | -30.8% |
2013/09/27 | 日証協 | 120,670株 | -14.82% | 69,554株 | -56.38% | 207,059株 | +56.34% | 115,621株 | +262.69% |
2013/09/20 | 日証協 | 141,670株 | -28.08% | 159,441株 | +69.9% | 132,440株 | -22.44% | 31,879株 | -18.16% |
2013/09/13 | 日証協 | 196,991株 | -6.12% | 93,842株 | +51.36% | 170,761株 | -13.77% | 38,951株 | +39.11% |
2013/09/06 | 日証協 | 209,837株 | -1.87% | 62,000株 | -37.48% | 198,040株 | +8.79% | 28,000株 | +86.67% |
2013/08/30 | 日証協 | 213,837株 | -3.49% | 99,167株 | +87.11% | 182,040株 | -12.5% | 15,000株 | +150% |
2013/08/23 | 日証協 | 221,570株 | +2.31% | 53,000株 | -61.59% | 208,040株 | +0.48% | 6,000株 | -85.37% |
2013/08/16 | 日証協 | 216,570株 | +2.15% | 138,000株 | +29.86% | 207,040株 | +9.27% | 41,000株 | +385.95% |
2013/08/09 | 日証協 | 212,007株 | -13.05% | 106,265株 | +85.32% | 189,477株 | -14.94% | 8,437株 | -85.84% |
2013/08/02 | 日証協 | 243,840株 | -6.72% | 57,340株 | -48.56% | 222,752株 | +1.96% | 59,591株 | +191.58% |
2013/07/26 | 日証協 | 261,420株 | -7.76% | 111,480株 | +9999.99% | 218,477株 | -14% | 20,437株 | +104.37% |
2013/07/19 | 日証協 | 283,420株 | -6.59% | 1,000株 | -99.15% | 254,035株 | -6.77% | 10,000株 | -88.8% |
※株式分割は考慮していませんのでご注意ください。
Page Top